Navigation Links
Rare Cancer- Subject of Study

Physicians at Wake Forest University Baptist Medical Center have developed new techniques that assist in the easy diagnosis of rare cancers. They published the results// of their study in the American Journal of Surgical Pathology. Robert F. Bradley, M.D said that tumors of the appendix that have metastasized through the abdominal cavity are all referred to as cancer. Bradley, a pathology resident, and colleagues studied 101 patients with pseudomyxoma peritonei, a rare form of cancer of the lining of the abdominal cavity. The cancer produces mucin, a jelly-like substance begins in the appendix or colon and spreads to the abdominal lining.

Wake Forest is one of a few centers in the country that offers surgery to remove the tumor and then infusion of heated chemotherapy drugs into the abdominal cavity. This type of cancer is rare and the treatment includes removal of appendices. After this the sections of the tumor are studied and classified it into three general categories: high-grade cancer, low-grade cancer, and benign. But patients in all the three groups are subjected to the same treatment. The classification is mainly to indicate the type of response generated by the patient. Patients from 1993 to 2005 were treated and found one-year, three-year and five-year survival rates were not significantly different for patients in the low-grade cancer and benign categories.

But those in the high-grade category had significantly worse survival. It is seen that there is no separate benign category but physicians should expect it to behave like low-grade cancer. If it is properly treated then it has a favorable prognosis. In conclusion he said that surgery plus abdominal chemotherapy known as intraperitoneal hyperthermic chemotherapy (IPHC) together is used in the treatment of tumors that had spread from the appendix, small bowels, ovaries, colon, rectum and stomach has improved the overall survival and quality of life.
'"/>




Page: 1

Related medicine news :

1. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Now A Cancer-Fighting Tomato
4. Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells
5. New Cancer-Blocking Algae Found
6. Cancer-Killing Compound From A Fungus
7. Cancer-Killing Viruses Employ Multiple Mechanisms
8. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
9. Head and Neck Cancer-Taxotere Approved
10. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
11. Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson & Peterson Construction ... Josh Christensen. As a leader in healthcare construction, AP has successfully built several ... in the Midwest with Josh now on board. , Josh brings over ...
(Date:7/18/2017)... Sherman Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... and Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking ... Ryan will be speaking on the therapeutic benefits of medical cannabis for both pediatric ...
(Date:7/18/2017)... ... , ... An inventor from Anacortes, Wash., knows the difficulties and indignity of ... flashes, and I suffer from anxiety and vertigo on top of that," she said, ... about." INSTA-FAN meets that need. , This device enables a woman in menopause to ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... and Its Treatments during Pregnancy , studies take a closer look at maternal ... a developing baby with one study showing newer medications may be safer choices. ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... today announced a partnership with the Texas Academy of Family Physicians (TAFP) ... place October 20-22, 2017 at the Hyatt Regency Dallas in Dallas, Texas.     , ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... 2017.  Members of its senior management team will host a conference ... a.m. ET. The dial-in number to access the ... 509-7598, and the passcode is 45397076. Please dial in 10 minutes ... A replay of the call will be available from ...
(Date:7/13/2017)...  New York City-based market research firm Kalorama Information notes ... of.  From new products to new costs, to the threat ... completed study, Potential Pipeline Disruptors . Among ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... impact the growing population and, to a more extreme extent, ...
(Date:7/11/2017)... N.J. , July 11, 2017  Bayer has awarded ... eight countries as part of its prestigious Bayer Hemophilia Awards ... Hospital of Philadelphia and Uniformed Services ... are among the winners. Grant recipients were announced last ... and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
Breaking Medicine Technology: